Be more productive and save money on app and subscription fees.

NotebookLM is your next productivity powerhouse ...

From fishing quotas in Norway to legislative accountability in California, investigative journalists share practical, ...

We present one of the first comprehensive evaluations of predictive information derived from retinal fundus photographs, ...

Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 million in an initial public offering, as listing activity in ...

Generate:Biomedicines is hoping to raise up to $425 million via a Nasdaq IPO, with the proceeds needed to bankroll its lead antibody through respiratory disease trials. The Flagship Pioneering-founded ...

Jake Peterson is Lifehacker’s Tech Editor, and has been covering tech news and how-tos for nearly a decade. His team covers all things technology, including AI, smartphones, computers, game consoles, ...

Add Yahoo as a preferred source to see more of our stories on Google. Researchers have demonstrated a particulate static effect-induced electricity generation technology inspired by the Tesla turbine.